Text Size
10 studies found for:    9516219 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Lovastatin: Immunomodulatory Value Evaluation
Condition: HIV Seropositivity
Interventions: Drug: Lovastatin;   Other: placebo
2 Completed Interleukin-2 With and Without Antiretroviral Therapy to Treat HIV-1 Infection
Conditions: HIV Infections;   HIV
Intervention: Drug: IL-2
3 Unknown † Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients
Condition: HIV Infections
Intervention: Drug: Kaletra
4 Unknown † Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir (drug)
5 Completed Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Enfuvirtide T/20/Ro 29,9800, HIV-1 Infusion Inhibitor
6 Completed A Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Medications With the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation Markers
Condition: HIV
Intervention: Drug: Atorvastatin
7 Completed Endothelial Dysfunction as a Risk Factor in HIV Study
Condition: HIV Infections
Interventions: Drug: Pravastatin;   Drug: Gemfibrozil;   Drug: Rosiglitazone
8 Completed Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children
Condition: HIV Infections
Intervention: Drug: HAART
9 Completed Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine
Condition: HIV Infection
Intervention:
10 Active, not recruiting Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Conditions: Immune Reconstitution Inflammatory Syndrome;   HIV;   HIV Infections
Interventions: Drug: maraviroc;   Drug: Placebo
To Top

† Indicates status has not been verified in more than two years